When a serious medical , pharmas and biotech M&A is taking place or in progress, a biotech, medical disagnostic or pharmas company will issue a confidential treatment order.
This may be seen as a regular piece of filing with the SEC, but to the biotech insiders, this is a very crucial piece of document.
A company may apply for a confidential treatment order by completing a confidential treatment request to keep information regarding a pricing arrangement made with a potential acquisition target secret. This request could be made on the basis that the company's competitors may use this information to go after the target with a more competitive price
NOW YOU KNOW THE REST OF THE STORY.IT IS JUST A MATTER OF TIME AND HOW MUCH.
ABSOLUTELY NO PUMPING AND PIMPING. JUST FACTS.
KNOW WHAT YOU OWN
TIM IS A SMART GUY. HE KNOWS HIS GAME VERY WELL. HE IS PLAYING BY THE TEXT BOOK